J5Q-27171-28851
3 vaccinations
1 coded response
29 check-ins
1 free-text entry
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 273 / NC
- Registered
- 2020-12-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
3ZM-11604-11789
Child or adolescent in my care · Female · 2022-01-28
PWS-31127-18397
Child or adolescent in my care · Female · 2022-01-28
Timeline
-
2020-12-30
Registered in v-safe
-
2020-12-30
Dose 1 — Moderna
- 2020-12-30
- 2020-12-31
-
2021-01-01
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Swelling · Headache, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-01
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
-
2021-01-02
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Nausea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-02
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-01-03
- 2021-01-04
- 2021-01-05
- 2021-01-06
- 2021-01-06
- 2021-01-09
- 2021-01-13
- 2021-01-20
- 2021-01-27
-
2021-01-28
Dose 2 — Moderna
- 2021-01-28
-
2021-01-29
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Swelling, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-30
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-01-31
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Muscle or body achesAdult check-in
- 2021-02-01
-
2021-02-02
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-02-03
- 2021-02-04
- 2021-02-11
- 2021-02-18
- 2021-02-25
- 2021-03-06
- 2021-03-13
- 2021-04-29
-
2021-11-27
Dose 3 — Moderna
-
2022-01-28
Survey response — 12 months, dose 2MedDRA: Unevaluable event — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text:MedDRA releases: 2024-11 · check-in free text available
- 2022-02-28
- 2022-05-28
- 2022-11-27
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-30 | Moderna | |
| 2 | 2021-01-28 | Moderna | |
| 3 | 2021-11-27 | Moderna | No |
Call center
2 call center cases
2 unsuccessful
Free text
Release 11 — 12 months, dose 2
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Unevaluable event | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release